SXTP

$2.38+0.13 (+5.78%)

Market OpenAs of Mar 17, 4:50 PM UTC

60 Degrees Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the United States.

OverviewIntradayAnalysisPROIntelligencePROAsk AIPRO

Historical Price

Price (Line)
50-Day SMA
200-Day SMA
Synthesizing Whystock Narrative...
Loading Financials...

Peer Comparison

JNJUNHPFE

Whystock Valuation Model

Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$2.38
Potential Upside
5%
Whystock Fair Value$2.50
Price
UndervaluedFair ValueOvervalued

Fundamentals

SectorHealthcare
IndustryBiotechnology

60 Degrees Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the United States. It offers Arakoda for malaria preventati...

Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$3.06M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
3.03
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Average efficiency. Growth may require heavy reinvestment.
-154.77%
Quick Ratio
Pristine liquidity. Sufficient cash to cover all near-term obligations.
2.18

Recent News

Insider Monkey
Feb 24, 2026

60 Degrees Pharmaceuticals (SXTP) Partners With GoodRx to Expand Access to ARAKODA

60 Degrees Pharmaceuticals Inc. (NASDAQ:SXTP) is one of the best up and coming penny stocks to buy. On February 2, 60 Degrees Pharmaceuticals announced a partnership with GoodRx to enhance the affordability and accessibility of ARAKODA (tafenoquine), the only FDA-approved, once-weekly prescription medication for malaria prevention in the US. The collaboration allows eligible patients to […]

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Simply Wall St.
Feb 8, 2026

Is GoodRx (GDRX) Using ARAKODA Discounts To Quietly Redefine Its Preventive Care Strategy?

In February 2026, 60 Degrees Pharmaceuticals announced a partnership with GoodRx to offer eligible U.S. consumers savings of up to 30% on ARAKODA, the only FDA-approved, once-weekly prescription malaria prevention, across more than 70,000 pharmacies and home delivery where available. This collaboration broadens GoodRx’s presence in travel-related preventive care, linking its discount platform to a specialized medication for malaria risk management. Next, we’ll examine how expanding into...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
MT Newswires
Jan 22, 2026

Sector Update: Health Care Stocks Mixed Late Afternoon

Health care stocks were mixed late Thursday afternoon, with the NYSE Health Care Index up 0.2% and t

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
MT Newswires
Jan 22, 2026

Top Midday Gainers

60 Degrees Pharmaceuticals (SXTP) reported Thursday a partnership with Runway Health to boost access

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
MT Newswires
Jan 22, 2026

Sector Update: Health Care Stocks Rise in Afternoon Trading

Health care stocks advanced Thursday afternoon, with the NYSE Health Care Index and the State Street

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.